GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » United Laboratories International Holdings Ltd (FRA:UNJ) » Definitions » Price-to-Owner-Earnings

United Laboratories International Holdings (FRA:UNJ) Price-to-Owner-Earnings : 8.69 (As of May. 14, 2024)


View and export this data going back to 2007. Start your Free Trial

What is United Laboratories International Holdings Price-to-Owner-Earnings?

As of today (2024-05-14), United Laboratories International Holdings's share price is €1.13. United Laboratories International Holdings's Owner Earnings per Share (TTM) ended in Dec. 2023 was €0.13. It's Price-to-Owner-Earnings for today is 8.69.


The historical rank and industry rank for United Laboratories International Holdings's Price-to-Owner-Earnings or its related term are showing as below:

FRA:UNJ' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.31   Med: 10.91   Max: 60
Current: 9.02

During the past 13 years, the highest Price-to-Owner-Earnings of United Laboratories International Holdings was 60.00. The lowest was 5.31. And the median was 10.91.


FRA:UNJ's Price-to-Owner-Earnings is ranked better than
89.76% of 420 companies
in the Drug Manufacturers industry
Industry Median: 28.12 vs FRA:UNJ: 9.02

As of today (2024-05-14), United Laboratories International Holdings's share price is €1.13. United Laboratories International Holdings's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.19. Therefore, United Laboratories International Holdings's PE Ratio for today is 5.92.

As of today (2024-05-14), United Laboratories International Holdings's share price is €1.13. United Laboratories International Holdings's EPS without NRI for the trailing twelve months (TTM) ended in was €0.19. Therefore, United Laboratories International Holdings's PE Ratio without NRI for today is 5.95.

During the past 13 years, United Laboratories International Holdings's highest PE Ratio without NRI was 70.76. The lowest was 3.94. And the median was 12.24.


United Laboratories International Holdings Price-to-Owner-Earnings Historical Data

The historical data trend for United Laboratories International Holdings's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

United Laboratories International Holdings Price-to-Owner-Earnings Chart

United Laboratories International Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.71 11.00 6.60 6.22 6.08

United Laboratories International Holdings Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.60 - 6.22 - 6.08

Competitive Comparison of United Laboratories International Holdings's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, United Laboratories International Holdings's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


United Laboratories International Holdings's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, United Laboratories International Holdings's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where United Laboratories International Holdings's Price-to-Owner-Earnings falls into.



United Laboratories International Holdings Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

United Laboratories International Holdings's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=1.13/0.13
=8.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


United Laboratories International Holdings  (FRA:UNJ) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


United Laboratories International Holdings Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of United Laboratories International Holdings's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


United Laboratories International Holdings (FRA:UNJ) Business Description

Traded in Other Exchanges
Address
No. 6 Fuk Wang Street, Yuen Long Industrial Estate, New Territories, Hong Kong, HKG
United Laboratories International Holdings Ltd is a major drug manufacturing company. United Laboratories is organized into three revenue streams, including Intermediate products, Bulk medicine, and Finished products. The company's Finished products segment includes antibiotic products, insulin series products, and other medicines. The vast majority of the company's revenue is derived from its Bulk medicine segment, followed by Finished products. Most of the company's sales are generated in China, followed by Europe and India.

United Laboratories International Holdings (FRA:UNJ) Headlines

No Headlines